3 ‘Buy’ recommendation by Nomura, with up to 28% upside

Nomura has upgraded IndusInd Bank to ‘Buy’ and increased its target price by 28% due to a clean-up of its books and strong retail business. They have also maintained ‘Neutral’ ratings for Voltas and Sun Pharma, with target prices of Rs 1,290 and Rs 1,970, respectively. Sun Pharma’s recent management changes are seen as a […]